Rising Liver Disease Cases Drive Growth In Liver Metastases Treatment Market Driving Market Acceleration in the Liver Metastases Treatment Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Liver Metastases Treatment Market Size By 2025?
The market for treating liver metastases has seen significant growth in the past few years. It is projected to increase from $1.57 billion in 2024 to $1.71 billion in 2025, with a compound annual growth rate (CAGR) of 8.9%. The previous growth can be credited to the development of personalized medicine, broader healthcare access, improved multidisciplinary care, and strides made in clinical trials and research.

How Big Is the Liver Metastases Treatment Market Size Expected to Grow by 2029?
In the coming years, the market size for liver metastases treatment is projected to significantly increase. By 2029, it is expected to reach a value of $2.37 billion, growing at a compound annual growth rate (CAGR) of 8.5%. This growth during the forecast period is a result of factors like patient-centric care models, precision medicine, shift to outpatient and ambulatory care, and regulatory efforts. Upcoming trends in this period are likely to include advancements in next-generation sequencing technologies and immuno-oncology, introduction of liquid biopsy technologies, and the use of adjuvant therapies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/liver-metastases-treatment-global-market-report

Which Key Market Drivers Powering Liver Metastases Treatment Market Expansion and Growth?
The escalating instances of liver disorders are anticipated to enhance the expansion of the liver metastases treatment market in the future. Disorders affecting the liver could inhibit its functioning or fail it completely. Treatments for metastases play a crucial role in promoting overall well-being by guarding liver function, crucial for metabolic processes, detoxification, and other vital bodily functions. In certain scenarios, meticulous treatments like surgical resection, ablation, or targeted therapies are required for extended remission, particularly when combined with systemic drugs such as chemotherapy or immunotherapy. For example, Cancer Australia, an Australian governmental cancer agency, reported roughly 2,905 new liver cancer cases in Australia in September 2022, (2,113 males and 792 females). Additionally, the chances of developing liver cancer by 85 years old is projected to be 1 in 103 (or 0.97%) in 2022, 1 in 70, or 1.4%, for males, and 1 in 195, or 0.51%, for females. Consequently, the rising instances of liver disease are boosting the liver metastases treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15849&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Liver Metastases Treatment Market?
Prominent players in the liver metastases treatment market are prioritizing the development and launch of liver-directed therapies, which offer a targeted and effective treatment option. These therapies specifically focus on diseases or conditions impacting the liver, treating liver metastases by zeroing in on cancer cells in the liver. These cells can either be directly eliminated or deprived of their blood supply through procedures such as surgical resection, radiofrequency ablation, transarterial chemoembolization, radioembolization, and stereotactic body radiation therapy. For example, Delcath Systems Incorporated, an American interventional oncology firm, unveiled Hepzato kit in August 2023. This liver-directed treatment is designed for adult patients suffering from metastatic uveal melanoma (mUM) with inoperable hepatic metastases impacting less than 50% of the liver. It's also suitable for patients with no or limited extrahepatic disease that can be removed surgically or treated with radiation. The Hepzato kit includes melphalan, a chemotherapy drug, which is delivered directly to the liver using Delcath's Hepatic Delivery System (HDS). This system maximizes drug exposure to the target tissues while minimizing systemic toxicity.

What Are the Emerging Segments in the Liver Metastases Treatment Market?
The liver metastases treatment market covered in this report is segmented -

1) By Treatment Type: Chemotherapy, Targeted Therapy, Immunotherapy
2) By Primary Cancer: Colorectal Cancer, Breast Cancer
3) By Distribution Channel: Hospital Pharmacies, Specialty Pharmacies

Subsegments:
1) By Chemotherapy: Cytotoxic Chemotherapy, Neoadjuvant Chemotherapy, Adjuvant Chemotherapy
2) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), Monoclonal Antibodies, MTOR Inhibitors
3) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Transfer Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15849&type=smp

Who Are the Global Leaders in the Liver Metastases Treatment Market?
Major companies operating in the liver metastases treatment market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol Myers Squibb, AstraZeneca plc, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim, Gilead Sciences Inc., Takeda Pharmaceutical Company, Astellas Pharma Inc., Daiichi Sankyo Company Ltd., Eisai Co. Ltd., Incyte Corporation, Ipsen, Seattle Genetics, Exelixis Inc., Array BioPharma Inc., Genentech Inc., Clovis Oncology, Agios Pharmaceuticals Inc., Taiho Pharmaceutical Co.Ltd

Which are the Top Profitable Regional Markets for the Liver Metastases Treatment Industry?
North America was the largest region in the liver metastases treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver metastases treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15849

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.